Largemulti-centerGWAstudieshavefoundassociationsbetweenover20genomiclociandlate-onset Alzheimer?sdisease(LOAD).However,theprecisetargetgenes,thecausalgeneticvariantsandtheir molecularmechanismsofactionthroughwhichtheyexerttheirpathogeniceffectsremainlargelyunknown. Ourlong-termgoalistoelucidatecausalgeneticfactorsandtheirfunctionaleffectsthatcontributetotheriskof developingLOAD.Ourcentralhypothesisisthatchangesinexpressionlevelsofcriticaldiseasegenesisan importantmolecularmechanismunderlyingLOADetiologyandthatcausalvariantsmodulateexpressionof thesediseasegenes,andbythatcontributetoLOADrisk.ChangesingeneexpressioninLOADvs.healthy controlsweredescribedinbraintissuesbyourteamandothersandpreviousstudiesreportedthecis- associationsoftaggingSNPswithexpressionofnearbyLOAD-riskgenes,providingastrongscientificpremise fortheproposedstudy.Inthisstudy,wewillemployamultifacetedapproachthatcombinesinsilico,invitro andinvivomethodstoinvestigateregionsinthegenomethatweresignificantlyassociatedwithLOAD-riskin GWAstudies.
In Aim1 wewillidentifytargetgeneswithinLOAD-associatedregionsthatshowdifferential expressionalongtheneuropathologicalprogressionofLOAD.Wewilldeterminetheexpressionprofileof geneswithintheseregionsinneurons,astrocytesandmicrogliaisolatedfromaffectedandunaffectedrapidly autopsiedhumanbraintissuesusinglasercapturemicrodissection(LCM)coupledwithnCountersinglecell geneexpressiontechnology(NanoString).
Aim2 willdiscoverregulatorynoncodingsequenceswithinLOAD- associatedregions.First,wewillprioritizecandidateregulatoryelementsusingbioinformaticstoolsandhuman genomedatabases,aswellasATAC-sequencingexperimentsusingNeuN+/-nucleifromaffectedand unaffectedhumanbraintissuestodeterminechromatinaccessibilityprofilesincelltype-andpathological stage-specificmanners.Thefunctionalityofthecandidatenoncodingsequenceswillbethencharacterized usingiPSC-derivedmodelsystemsthatwillbegenomeeditedtocarrydeletionsofthepredictedregulatory sequences.
Aim3 willfocusonShortStructuralVariants(SSVs)andwillinvestigatethefunctionaleffectsand causalityofSSVsinthecandidateregulatorysequences.WewilluseSMRTsequencingcombinedwithCas9 system(PacBio)toaccuratelydeterminetheSSVsgenotypeandhaplotypesinLOADcomparedtocontrol subjects,andwillexaminetheirregulatoryeffectsusinggenomeeditedisogeniciPSC-derivedneuronsand/or astrocytesmodelsthatcarrydifferentalleles/haplotypesattheSSVsite.Ourstudywilladvancethe identificationofcausalgeneticfactorsandtheunderstandingoftheirmoleculareffectsthatcontributetothe riskofdevelopingLOAD.Thisknowledgewillprovideinsightregardingactionabletargetsfordevelopmentof noveltherapiesforLOAD.Furthermore,theidentifiedSSVswilladvancethedevelopmentofgenetic biomarkersforearlydiagnosisandforenrichmentofclinicaltrialswithsubjectsathighrisk.
LateonsetAlzheimer?sdisease(LOAD)isacriticalunmetmedicalneed.Thediseaseprocessstartsdecades beforeplaquesortangleneuropathologiesaredetectable,andalthoughgeneticscontributestotheriskto developLOADtheprecisegeneticfactorsandtheirmechanismsofactionremainlargelyunknown.Ourstudy seekstouncoverthegeneticdeterminantsandmolecularmechanismsunderpinningLOAD.Understandingthe geneticfactorsaffectingtheetiologyofLOADwillleadtothediscoveryofpreventivetherapiestargeting moleculareventsthatoccurearly;?yearsbeforethemanifestationofneuropathologicalchangesandclinical symptoms.